Expanding Chaetocin-Based Therapies to Novel Hearing Loss Prevention and Treatment Applications

Publication ID: 24-11857551_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Expanding Chaetocin-Based Therapies to Novel Hearing Loss Prevention and Treatment Applications,” Published Technical Disclosure No. 24-11857551_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857551_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,551.

Summary of the Inventive Concept

This inventive concept leverages the core technology of chaetocin-based compounds to prevent and treat hearing loss in new, high-impact industries, including aviation, military, music, construction, and sports.

Background and Problem Solved

While the original patent focuses on preventing and treating hearing loss caused by chemotherapeutic agents, this new inventive concept addresses the unmet need for effective hearing loss prevention and treatment solutions in diverse industries, where loud noise exposure is a significant occupational hazard.

Detailed Description of the Inventive Concept

The inventive concept involves administering chaetocin-based compounds to protect the inner ear cells from death caused by loud noise exposure in various settings. For instance, in pilots, chaetocin can be administered to prevent noise-induced hearing loss. In soldiers, a pharmaceutical composition comprising chaetocin can be administered prior to exposure to explosive noise. Similarly, in musicians, a topical composition comprising chaetocin can be applied to the outer ear to prevent hearing loss. In construction workers, a noise-cancelling earpiece with a dispenser for administering chaetocin can be used. In swimmers, a topical composition comprising chaetocin can be applied to the outer ear prior to swimming.

Novelty and Inventive Step

The new claims introduce novel applications of chaetocin-based compounds in diverse industries, which were not originally considered in the original patent. The inventive step lies in recognizing the potential of these compounds to prevent and treat hearing loss in these new settings, and developing specific formulations and delivery methods tailored to each industry's unique needs.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include using different analogs of chaetocin, varying the administration routes and dosages, or combining chaetocin with other therapeutic agents to enhance its efficacy. Additionally, the inventive concept can be adapted for use in other industries, such as manufacturing, emergency response, or transportation, where noise exposure is a significant risk.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including aviation, military, music, construction, and sports, where hearing loss prevention and treatment are critical concerns. The market for hearing loss prevention and treatment solutions is substantial, and this inventive concept offers a novel, effective, and targeted approach to addressing this need.

Original Patent Information

Patent NumberUS 11,857,551
TitleMethods for the prevention and treatment of hearing loss
Assignee(s)Ting Therapeutics LLC